DEFINITIVE PROXY STATEMENT

Company

IGC Pharma, Inc.

Filed

February 8, 2008

Period of Report

February 20, 2008

Accession Number

0001206774-08-000283

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →